Allergy, Asthma, and Atopic Eczema in Finland - A Nationwide Study on Prevalence, Comorbidities, Treatment and Economic Burden
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 2,000,000
- 试验地点
- 1
- 主要终点
- Burden of atopic diseases (allergies, asthma, and atopic eczema) as well as comorbidities in Finland
研究概览
简要总结
The summary is available at --> https://www.finnatopy.fi/summary
详细描述
Aims and objectives ---> https://www.finnatopy.fi/aims-and-objectives Methods ---> https://www.finnatopy.fi/methods
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Burden of atopic diseases (allergies, asthma, and atopic eczema) as well as comorbidities in Finland
时间窗: 7 years
Morbidity, sick leaves, medication use, costs and expences
Use and effectiveness of allergen immunotherapy in real world setting
时间窗: 7 years
Real world evidence data using specific cohorts
Epidemiology of atopic diseases and allergic sensitization profiles in Finland
时间窗: 7 years
Incidence and prevalence of asthma, specific IgE sensitization, atopic dermatitis, allergic rhinitis
Evaluate and improve the current use of diagnostic tests for atopic diseases
时间窗: 7 years
Diagnostic practices, tests for allergic sensitization, lung function tests, and other laboratory measures.
Direct and indirect costs related to atopic diseases and comorbidities
时间窗: 7 years
All costs, including sick leaves, absenteeism, laboratory costs, other diagnisteic tests, etc.
次要结局
未报告次要终点
研究者
Peter Csonka
MD, PhD, Associate professor of pediatrics
Tampere University